The mPFC molecular clock mediates the effects of sleep deprivation on depression-like behavior and regulates sleep consolidation and homeostasis
Wilf Gardner, David H. Sarrazin, Martin Balzinger, Carole Marchese, Axelle Ragno, Chockalingam Ramanathan, Maxime Veleanu, Stefan Vestring, Claus Normann, Patrice Bourgin, Tsvetan Serchov
Molecular Psychiatry March 1, 2026 DOI: 10.1038/s41380-025-03276-7 via Springer Nature
Summary
AI-generated from the abstractDisruptions in sleep, circadian rhythms, and neural plasticity are closely linked to depression. Using a mouse model of stress-induced depression, the authors found altered sleep architecture, impaired sleep homeostasis, and disrupted day-night oscillations of glutamatergic plasticity markers Homer1a and synaptic AMPAR expression in the medial prefrontal cortex (mPFC). Sleep deprivation (SD) and ketamine, both rapid-acting antidepressants, exerted opposing effects on mPFC circadian gene expression: SD enhanced negative clock loop genes (Per, Cry), while ketamine downregulated them. Targeted deletion of the core clock gene Bmal1 in mPFC excitatory neurons disrupted sleep-wake architecture and abolished the behavioral and molecular response to SD. Pharmacological activation of the clock repressor REV-ERB suppressed SD's antidepressant effects. The mPFC molecular clock is essential for sleep consolidation and homeostasis and mediates SD's behavioral effects.
Study at a glance
| Characteristics | Animal study Peer reviewed |
|---|---|
| Population | Mouse model of stress-induced depression |
| Interventions | Sleep deprivation ketamine |
| Key finding | The mPFC molecular clock is essential for sleep consolidation and homeostasis and mediates the antidepressant effects of sleep deprivation. |
Abstract
Disruptions in sleep, circadian rhythms, and neural plasticity are closely linked to the pathophysiology and treatment of depression. Acute sleep deprivation (SD) produces rapid but transient antidepressant effects, yet the underlying mechanisms remain poorly understood. Using a mouse model of stress-induced depression, we found altered sleep architecture, impaired sleep homeostasis, and disrupted day-night oscillations of the markers of glutamatergic plasticity - Homer1a and synaptic AMPAR expression in the medial prefrontal cortex (mPFC). These changes were accompanied by a blunted homeostatic response to SD. We further show that SD and ketamine, both rapid-acting antidepressants, exert opposing effects on mPFC circadian gene expression: SD enhances the expression of negative clock loop genes (e.g., Per , Cry ), mirroring stress effects, while ketamine downregulates these same genes. Targeted deletion of the core clock gene Bmal1 in CaMK2a-expressing excitatory neurons of the mPFC disrupted sleep-wake architecture, elevated slow-wave activity, and abolished the behavioral and molecular (Homer1a) response to SD. Additionally, pharmacological activation of the clock repressor REV-ERB suppressed the antidepressant effects of SD. Our results demonstrate that the mPFC molecular clock is essential for the regulation of sleep consolidation and homeostasis, and mediates the effects of SD on behavior.